DV Stent Bronchial

You are here:

DV Stent Bronchial

Basic description

The DV Stent Bronchial is a worldwide unique self-expandable bronchial biodegradable stent that degrades in the human body usually 3 to 4 months after the implantation. Therefore, it is an ideal solution for temporary use in benign indications, where it is not necessary to extract it from the body like other non-degradable stents.

Product is available as a custom-made device.

CE mark pending

Indication

DV Stent Bronchial is intended for patients aged 18 and older and is indicated for the treatment of benign bronchial strictures or bronchomalacia.

Features / Benefits

The DV Stent Bronchial degrades in the human body usually in 3 to 4 months. This reduces the number of interventions and hospital visits.
The stent is made of polydioxanone, an absorbable material (polymer) used in medicine as a surgical suture for more than 30 years.
Stent integrity and radial force are maintained for 6 to 8 weeks of implantation. Subsequently, the radial force gradually decreases until the degradation of the material after 3 to 4 months.
The pH value affects the stent degradation process. In the conditions of the human body, stent degradation is slower at higher (neutral) pH, while stent degradation is faster at lower (acidic) pH.
Low migration is achieved by an uncovered stent design.
Polydioxanone is not visible under X-ray, therefore the stent is equipped with gold markers – 1 piece at both stent ends.
MRI compatibility – “MR Conditional”, compatible with 1.5 Tesla and 3 Tesla static magnetic field.

Implantation

The stent is supplied sterile and is packed separately from the delivery system. Just prior to implantation, the stent must be manually compressed into the delivery system. The stent is inserted under bronchoscopic and/or fluoroscopic control. We recommend using a 0.035 ”(0.89 mm) guidewire for the implantation.

DV stent bronchial compression

Available sizes

REFNominal stent body
diameter [mm]
Nominal stent length [mm]Delivery system
019-IU-08-020-DV82011,8 F / 60 cm
019-IU-08-030-DV30
019-IU-08-035-DV35
019-IU-10-020-DV1020
019-IU-10-025-DV25
019-IU-10-030-DV30
019-IU-10-035-DV35
019-IU-12-020-DV122015 F / 60 cm
019-IU-12-025-DV25
019-IU-12-030-DV30
019-IU-12-035-DV35
019-IU-12-040-DV40
019-IU-12-045-DV45
019-IU-14-020-DV142018 F / 60 cm
019-IU-14-030-DV30
019-IU-14-035-DV35
019-IU-14-040-DV40
019-IU-14-045-DV45

Publications

van Pel R, Gan T, Daniels JMA, Ruigrok D, Hellemons ME, Klooster K, Slebos DJ

Clin Transplant. 2024 Mar;38(3):e15289. doi: 10.1111/ctr.15289. PMID: 38486062.

Gottlieb J, Fuehner T, Zardo P.

Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231181541. doi: 10.1177/17534666231181541. PMID: 37526226; PMCID: PMC10395170.

Lischke R, Pozniak J, Vondrys D, Elliott MJ.

Eur J Cardiothorac Surg. 2011 Sep;40(3):619-24. doi: 10.1016/j.ejcts.2010.12.047. Epub 2011 Feb 21. PMID: 21334911.

Federico Minen, Andrew Durward, Paul James, Athanasios Diamantopoulos, Haran Jogeesvaran, Gareth J Morgan, Andrew Nyman

Pediatr Pulmonol. 2023;1‐10., DOI: 10.1002/ppul.26670, PMID: 37728230 

Rocío Morante-Valverde, María López Díaz, Mª Carmen Luna-Paredes, Sara Proaño, Cecilia Castellano, Mª Dolores Méndez, Victoria Ramos, Juan L Antón-Pacheco

Pediatr Pulmonol. 2024 Oct;59(10):2517-2522. doi: 10.1002/ppul.27056. Epub 2024 May 9. PMID: 38721899

Vondrys D, Elliott MJ, McLaren CA, Noctor C, Roebuck DJ

Ann Thorac Surg. 2011 Nov;92(5):1870-4. doi: 10.1016/j.athoracsur.2011.07.042. Epub 2011 Oct 31. PMID: 22051281

 
For more information on publications, visit our Education section.